Winter 2019 QUEST
The publication of Dr. Catalona and the Urological Research Foundation
Features
- Understanding PSA Screening: A Short History of Early Detection for Prostate Cancer and Its Impact
- Q&A with Dr. Catalona
- Andrew Fox Goes Full Steam Ahead
- Spotlight on Men’s Health: Testosterone Deficiency — An Interview with Dr. Joshua Halpern
- A Message from Dr. Catalona
Screening and Detection
- Other Pieces of the Puzzle: More Strategies for the Early Detection of Prostate Cancer
- Artificial Intelligence: Future Technology for Cancer Diagnostics
Cancer Treatment
- First Prostate Cancer Therapy to Target Genes Delays Cancer Progression
- New Approaches in Personalized Medicine: Genomic Testing to Predict Early ADT Response
- Breakthroughs in Treatment: FDA Approves Apalutamide for Metastatic Hormone-Sensitive Prostate Cancer
Prostate Cancer Risk Factors
- Examining More Data: BPH and Baldness Drugs, PSA Suppression, and the Risk of Dying from Prostate Cancer
- Long-Term Smokers More Likely to Have Cancer Recurrence
Opportunities to Get Involved with Research
All QUEST material is under copyright and cannot be duplicated for any reason other than personal use.